In terms of clinical and pathological observations, we report a positive correlation between LMP1/GLUT1 expression in malignant cells and the abundance of CD33+ MDSCs in the NPC tumor microenvironment. The gene discussed is CD33; the disease is nasopharyngeal carcinoma.